Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

June 2003 · Vol. 15, No. 6

Polycystic ovary syndrome:
3 key challenges

Newer findings have broadened options for medical management of insulin resistance, anovulation, and hyperandrogenism.


DALE  W.  STOVALL,  MD

Dr. Stovall is associate professor of reproductive endocrinology in the department of obstetrics and gynecology at Virginia Commonwealth University Health Systems in Richmond, Va.

KEY POINTS

  • Women with PCOS and insulin resistance are at increased risk for impaired glucose tolerance or diabetes. Hypoglycemic agents can reduce circulating androgen levels, increase sex hormone binding globulin, facilitate weight loss, and induce ovulation.

  • Take steps to enhance or induce ovulation. Even women who do not desire fertility stand to gain, because chronic anovulation increases the risk of endometrial cancer.

  • Address hirsutism and other hyperandrogenic effects. Treatment of hirsutism is best approached with a combination of medical and mechanical means. Counsel patients that response is likely to be slow and subtle.

An expanded array of pharmacologic combinations and regimens has increased our options for treating women with polycystic ovary syndrome (PCOS).

Managing PCOS has always been a complex process, due to the wide range of troubles experienced by patients with this disorder. An effective treatment strategy should address the 3 clinical challenges typical of the syndrome:

Sign in now to read more...

Back to top


Advertisement



Advertisement1


XMLRSS callout
 

Advertisement